MedPath

The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality

Completed
Conditions
Diabete Type 2
Registration Number
NCT06188572
Lead Sponsor
Bandırma Onyedi Eylül University
Brief Summary

The aim of this observational case-control study was to investigate the effect of diabetic peripheral neuropathy symptoms on temporomandibular joint functionality in patients with type 2 diabetes.

Detailed Description

The number of participants planned to be included in the study was decided with the G-Power programme. While calculating the number of individuals to be included in the study, it was calculated that the sample size to obtain an effect size of 0.6 for the purpose of evaluation within the 95% confidence interval in a way to provide 80% study power at 5% Type 1 and 20% Type 2 error limits should be 74 (n=37) individuals. This study included 70 individuals (DM study group=40 individuals, control group=30 individuals).

Peripheral neuropathy symptoms of all participants were evaluated with the Michigan Neuropathy Screening Test. In the evaluation of TMJ functionality, the presence of pain, maximum pain-free mouth opening, mandibular dysfunction and dysfunction were assessed with the help of scales. Duration of diabetes mellitus was recorded and quality of life was evaluated with Ferran Powers Quality of Life Index.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Individuals diagnosed with type 2 DM
Exclusion Criteria
  • Having diabetic foot ulcer,
  • Mini Mental Test score below 24,
  • History of psychiatric illness, cancer, neurological problems, congenital anomalies, musculoskeletal problems, systemic disease, facial paralysis, surgical operation related to spine, abdomen and/or TMJ problem
  • Receiving any treatment related to spine and TMJ in less than 6 months

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Michigan Neuropathy Screening InstrumentMay 2023- November 2023

The symptom questionnaire includes 15 questions about the legs and feet. Physical examination includes assessment of the appearance of the feet, Achilles reflex, thumb vibration and monofilament tests.

High score indicates increased neuropathy

Ferrans&Powers Quality of Life Index Diabetes VersionMay 2023- November 2023

The Quality of Life Assessment Index consists of two parts and a total of 68 items. A high score indicates a good quality of life

Numeric Pain ScaleMay 2023- November 2023

The participant is asked to mark a number on a 10 cm scale, on which numbers are shown in the range of "0" (no pain) to "10" (unbearable pain) for the pain. High score indicates increased pain

Mandibular Function Disorder QuestionnaireMay 2023- November 2023

This scale evaluating mandibular dysfunction consists of two dimensions and 17 questions.A high total score obtained from the questionnaire indicates a high level of impairment in jaw function.

Fonseca Anamnestic IndexMay 2023- November 2023

This scale includes 10 questions. The presence of TMD is accepted in those with a score of 25. High score indicates increased dysfunction.

Maximum pain-free mouth openingMay 2023- November 2023

The maximum pain-free mouth opening was recorded using a 15 cm ruler

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bandirma Onyedi Eylul University

🇹🇷

Balıkesir, Bandirma, Turkey

Bandirma Onyedi Eylul University
🇹🇷Balıkesir, Bandirma, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.